{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:16:46Z","timestamp":1759882606796,"version":"build-2065373602"},"reference-count":27,"publisher":"BMJ","issue":"13","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1139133","APP1147430","GNT1196900"],"award-info":[{"award-number":["APP1139133","APP1147430","GNT1196900"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["105609"],"award-info":[{"award-number":["105609"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,2,13]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the comparative effectiveness of postdischarge use of varenicline versus prescription nicotine replacement therapy (NRT) patches for the prevention of recurrent cardiovascular events and mortality and whether this association differs by sex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Our cohort study used routinely collected hospital, pharmaceutical dispensing and mortality data for residents of New South Wales, Australia. We included patients hospitalised for a major cardiovascular event or procedure 2011\u20132017, who were dispensed varenicline or prescription NRT patches within 90day postdischarge. Exposure was defined using an approach analogous to intention to treat. Using inverse probability of treatment weighting with propensity scores to account for confounding, we estimated adjusted HRs for major cardiovascular events (MACEs), overall and by sex. We fitted an additional model with a sex\u2013treatment interaction term to determine if treatment effects differed between males and females.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our cohort of 844 varenicline users (72% male, 75% &lt;65 years) and 2446 prescription NRT patch users (67% male, 65% &lt;65 years) were followed for a median of 2.93 years and 2.34 years, respectively. After weighting, there was no difference in risk of MACE for varenicline relative to prescription NRT patches (aHR 0.99, 95% CI 0.82 to 1.19). We found no difference (interaction p=0.098) between males (aHR 0.92, 95% CI 0.73 to 1.16) and females (aHR 1.30, 95% CI 0.92 to 1.84), although the effect among females deviated from the null.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We found no difference between varenicline and prescription NRT patches in the risk of recurrent MACE. These results should be considered when determining the most appropriate choice of smoking cessation pharmacotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-322170","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:06:51Z","timestamp":1678946811000},"page":"1016-1024","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-1118","authenticated-orcid":false,"given":"Annelies L","family":"Robijn","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Randwick, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian B","family":"Filion","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-5296","authenticated-orcid":false,"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, UNSW Sydney, Camperdown, New South Wales, Australia"},{"name":"The George Institute for Global Health, School of Public Health, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9951-6511","authenticated-orcid":false,"given":"Benjumin","family":"Hsu","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, UNSW Sydney, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-0038","authenticated-orcid":false,"given":"Clara K","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Westmead, New South Wales, Australia"},{"name":"Department of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"School of Population Health, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa","family":"Jorm","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, UNSW Sydney, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6444-7272","authenticated-orcid":false,"given":"Michael O","family":"Falster","sequence":"additional","affiliation":[{"name":"School of Population Health, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alys","family":"Havard","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Randwick, New South Wales, Australia"},{"name":"School of Population Health, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2025100702281083000_109.13.1016.1","unstructured":"Global Burden of Disease Collaborative Network . Global burden of disease database. 2019. Available: https:\/\/vizhub.healthdata.org\/gbd-results\/ [Accessed 20 Jun 2022]."},{"key":"2025100702281083000_109.13.1016.2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2019.03.019","article-title":"Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease","volume":"213","author":"van den Berg","year":"2019","journal-title":"Am Heart J"},{"key":"2025100702281083000_109.13.1016.3","article-title":"Smoking cessation for secondary prevention of cardiovascular disease","volume":"8","author":"Wu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2025100702281083000_109.13.1016.4","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2022.03.377","article-title":"Cigarette smoking, cessation, and risk of heart failure with preserved and reduced ejection fraction","volume":"79","author":"Ding","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025100702281083000_109.13.1016.5","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025100702281083000_109.13.1016.6","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-016-0004-8","article-title":"National guidelines for smoking cessation in primary care: a literature review and evidence analysis","volume":"27","author":"Verbiest","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"key":"2025100702281083000_109.13.1016.7","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"2016","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025100702281083000_109.13.1016.8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025100702281083000_109.13.1016.9","unstructured":"U.S. Department of Health and . Smoking cessation. A report of the surgeon general. Atlanta GA, 2020. Available: http:\/\/profiles.nlm.nih.gov\/ps\/access\/NNBBHB.ocr"},{"key":"2025100702281083000_109.13.1016.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69249-0"},{"key":"2025100702281083000_109.13.1016.11","first-page":"273","article-title":"Sex differences in smoking cessation pharmacotherapy comparative efficacy: a network meta-analysis","volume":"19","author":"Smith","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"2025100702281083000_109.13.1016.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025100702281083000_109.13.1016.13","unstructured":"National Centre for Classification in Health . The international statistical classification of diseases and related health problems, tenth revision, Australian modification (ICD-10-AM). 5th edn. Sydney: Faculty of Health Sciences, The Universtiy of Sydney, 2008."},{"key":"2025100702281083000_109.13.1016.14","unstructured":"National Centre for Classification in Health . Australian classification of health interventions. 7th edn. Faculty of Health Sciences, The Universtiy of Sydney, 2010."},{"key":"2025100702281083000_109.13.1016.15","unstructured":"Australian Government Department of Health . Pharmaceutical benefits. fees, patient contributions and safety net thresholds. Available: https:\/\/www.pbs.gov.au\/info\/healthpro\/explanatory-notes\/front\/fee [Accessed 2 Sep 2021]."},{"key":"2025100702281083000_109.13.1016.16","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/eurjpc\/zwac172","article-title":"Uptake of prescription smoking cessation pharmacotherapies after hospitalization for major cardiovascular disease","volume":"29","author":"Robijn","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2025100702281083000_109.13.1016.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2025100702281083000_109.13.1016.18","unstructured":"Australian Bureau of Statistics . Index of relative socio-economic disadvantage (IRSD) Australia 2011. 2011. Available: https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/2033.0.55.001main+features100052011 [Accessed 17 Jun 2021]."},{"key":"2025100702281083000_109.13.1016.19","unstructured":"Australian Bureau of Statistics . Australian standard geographical classifiation 2011. 2011. Available: https:\/\/www.abs.gov.au\/websitedbs\/d3310114.nsf\/home\/australian+standard+geographical+classification+(asgc) [Accessed 17 Jun 2021]."},{"key":"2025100702281083000_109.13.1016.20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"2025100702281083000_109.13.1016.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2025100702281083000_109.13.1016.22","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315299"},{"key":"2025100702281083000_109.13.1016.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166992","article-title":"Comparative effectiveness of smoking cessation medications: a national prospective cohort from Taiwan","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"2025100702281083000_109.13.1016.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107442","article-title":"Real-World effectiveness of smoking cessation AIDS: a population survey in England with 12-month follow-up, 2015-2020","volume":"135","author":"Jackson","year":"2022","journal-title":"Addict Behav"},{"key":"2025100702281083000_109.13.1016.25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx109"},{"key":"2025100702281083000_109.13.1016.26","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.01414"},{"key":"2025100702281083000_109.13.1016.27","unstructured":"Pharmaceutical Benefits Advisory Committee . Post-market review of medicines for smoking cessation - section 2. 2021. Available: https:\/\/www.pbs.gov.au\/info\/reviews\/public-consultation-on-the-post-market-review-of-medicines [Accessed 31 Jan 2022]."}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-322170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:28:22Z","timestamp":1759829302000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-322170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":27,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/heartjnl-2022-322170"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-322170","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}